Literature DB >> 28119062

Baculovirus-based genome editing in primary cells.

Maysam Mansouri1, Zahra Ehsaei2, Verdon Taylor2, Philipp Berger3.   

Abstract

Genome editing in eukaryotes became easier in the last years with the development of nucleases that induce double strand breaks in DNA at user-defined sites. CRISPR/Cas9-based genome editing is currently one of the most powerful strategies. In the easiest case, a nuclease (e.g. Cas9) and a target defining guide RNA (gRNA) are transferred into a target cell. Non-homologous end joining (NHEJ) repair of the DNA break following Cas9 cleavage can lead to inactivation of the target gene. Specific repair or insertion of DNA with Homology Directed Repair (HDR) needs the simultaneous delivery of a repair template. Recombinant Lentivirus or Adenovirus genomes have enough capacity for a nuclease coding sequence and the gRNA but are usually too small to also carry large targeting constructs. We recently showed that a baculovirus-based multigene expression system (MultiPrime) can be used for genome editing in primary cells since it possesses the necessary capacity to carry the nuclease and gRNA expression constructs and the HDR targeting sequences. Here we present new Acceptor plasmids for MultiPrime that allow simplified cloning of baculoviruses for genome editing and we show their functionality in primary cells with limited life span and induced pluripotent stem cells (iPS).
Copyright © 2017 Elsevier Inc. All rights reserved.

Keywords:  Baculovirus; CRISPR/Cas9; Genome editing; Primary cells

Mesh:

Substances:

Year:  2017        PMID: 28119062     DOI: 10.1016/j.plasmid.2017.01.003

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  5 in total

Review 1.  Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools.

Authors:  Uijin Kim; Nahyun Kim; Ha Youn Shin
Journal:  Cells       Date:  2020-12-01       Impact factor: 6.600

2.  Highly efficient CRISPR-mediated large DNA docking and multiplexed prime editing using a single baculovirus.

Authors:  Francesco Aulicino; Martin Pelosse; Christine Toelzer; Julien Capin; Erwin Ilegems; Parisa Meysami; Ruth Rollarson; Per-Olof Berggren; Mark Simon Dillingham; Christiane Schaffitzel; Moin A Saleem; Gavin I Welsh; Imre Berger
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

Review 3.  The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy.

Authors:  Ning Guo; Ji-Bin Liu; Wen Li; Yu-Shui Ma; Da Fu
Journal:  J Adv Res       Date:  2021-12-04       Impact factor: 12.822

Review 4.  In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  F1000Res       Date:  2017-12-20

Review 5.  Synthetic Virus-Derived Nanosystems (SVNs) for Delivery and Precision Docking of Large Multifunctional DNA Circuitry in Mammalian Cells.

Authors:  Francesco Aulicino; Julien Capin; Imre Berger
Journal:  Pharmaceutics       Date:  2020-08-11       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.